Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/305
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharris, Jaime-
dc.contributor.authorBarazarte, Arthur-
dc.contributor.authorDomínguez, José-
dc.contributor.authorLobo, Gricela-
dc.contributor.authorCamacho, José-
dc.contributor.authorFerrer, Rosa-
dc.contributor.authorGamboa, Neira-
dc.contributor.authorRodrigues, Juan-
dc.date.accessioned2011-06-27T18:35:21Z-
dc.date.available2011-06-27T18:35:21Z-
dc.date.issued2007-05-
dc.identifier.urihttp://hdl.handle.net/10872/305-
dc.description.abstractA series of thieno[2,3-b]quinolone derivatives were synthesized and investigated for their abilities to inhibit 􀀁-hematin formation, hemoglobin hydrolysis and in vivo for their efficacy in rodent Plasmodium berghei. Compound 3b was the most promising as inhibitor of hemoglobin hydrolysis, and its effects as inhibitor of 􀀁-hematin formation was promising. When the aromatic ring was substituted in 2 (Me), in 3 (CF3) or in 2,4 (Cl) the inhibition of hemoglobin proteolysis was maximal (88%), the rest of compounds maintained a low inhibition. The most active compound to emerge in vitro and in murine studies, was 3b suggesting an antimalarial activity via multiple mechanisms.es_VE
dc.language.isoen_USes_VE
dc.publisherHeterocyclic Chem.,es_VE
dc.titleSynthesis and Antimalarial Activity of Ethyl 3-Amino-4-oxo-9- (phenylsubstituted)thieno[2,3-b]quinoline-2-carboxylate Derivatives.es_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
JHC2007.pdf354.39 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.